PMID: 2502384Jul 1, 1989Paper

Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study

Epilepsia
D LunaD Beaumont

Abstract

Sixty-one pediatric patients (12-229 months of age) with refractory epilepsy were treated with vigabatrin [gamma-vinyl GABA (GVG)] in a 16-week, single-blind, add-on, placebo-controlled trial. Twenty-three patients (38%) showed a reduction of more than 50% in seizure frequency; 12 patients (20%) experienced a seizure increase; and the remaining 26 did not show significant differences between placebo and GVG treatment. Among the 216 patients who entered the long-term phase after having experienced more than 50% decrease in seizure frequency, 14 continued with the same degree of improvement after 2-11 months of follow-up (mean 7.7). GVG was particularly efficient in cryptogenic partial epilepsy. Conversely, nonprogressive myoclonic epilepsy tended to be aggravated. Agitation was the most commonly observed side effect, mainly at onset of therapy in mentally retarded patients, but was easily reversed by dose reduction. GVG is a promising drug in the treatment of refractory epilepsies of childhood.

References

May 11, 1979·Brain Research·P BöhlenM G Palfreyman
Sep 1, 1979·Pharmacology, Biochemistry, and Behavior·M S MyslobodskyJ Engel
Sep 1, 1987·Archives of Neurology·C A TassinariF Salvi
Sep 1, 1985·Acta Neurologica Scandinavica·S A PedersenM Dam
Jan 1, 1982·Clinical Neuropharmacology·B Meldrum
Sep 25, 1981·Molecular and Cellular Biochemistry·M J Iadarola, K Gale
Jul 1, 1983·Acta Neurologica Scandinavica·L GramM Dam

❮ Previous
Next ❯

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
Sep 16, 2010·Current Treatment Options in Neurology·Laura A StromLauren Frey
Feb 10, 1990·Lancet·C ChironJ P Mumford
Sep 1, 1992·Pediatric Neurology·J M GibbsL Rosenbloom
Nov 1, 1992·Epilepsy Research·L M OjemannJ Wallace
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·James W WhelessStephen D Collins
Aug 15, 2000·Epilepsy Research·E PeruccaT Tomson
Jul 20, 2001·Epilepsy Research·O Dulac, R Guerrini
Nov 1, 1996·Epilepsy Research·C ChironL Gram
Jan 7, 1998·Epilepsy Research·J L GherpelliM A Chisté
Sep 1, 1995·Seizure : the Journal of the British Epilepsy Association·S J Wallace
Apr 1, 1995·Australian and New Zealand Journal of Medicine·C Kilpatrick
Jan 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Sabers, L Gram
Dec 16, 1998·Pediatric Nursing·J Calli, E Farrington
Jan 1, 1995·Epilepsia·B F Bourgeois
Jan 1, 1996·Epilepsia·L Gram
Nov 20, 1998·Epilepsia·C KuenzleB Schmitt
Apr 1, 1992·Pharmacology & Toxicology·A Sabers, L Gram
Oct 1, 1991·Archives of Disease in Childhood·N V O'Donohoe
Dec 1, 1991·Archives of Disease in Childhood·J H Livingston
Sep 1, 1996·Archives of Disease in Childhood·R E Appleton
May 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·J W SanderS D Shorvon
Apr 2, 2009·Neuropsychiatric Disease and Treatment·Kenou van Rijckevorsel
Feb 12, 2004·CNS Drugs·Giangennaro Coppola
Mar 3, 2010·CNS Drugs·Dean P Sarco, Blaise F D Bourgeois
Jan 22, 2003·Brain & Development·Ming-Tao YangYu-Zen Shen
May 1, 2002·Clinical Neuropharmacology·Mohamad A MikatiGregory L Holmes
Dec 19, 1992·Lancet·M G MarcianiL Orlandi
Oct 13, 2000·Fundamental & Clinical Pharmacology·M S Benedetti
Jan 24, 2002·Therapeutic Drug Monitoring·Houda HachadRene H Levy
Oct 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R Nabbout
Feb 13, 2009·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Colin D Ferrie, Amit Patel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.